nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Prostate carcinoma—Riluzole—amyotrophic lateral sclerosis	0.069	0.069	CcSEcCtD
Tolcapone—Prostate cancer—Riluzole—amyotrophic lateral sclerosis	0.0339	0.0339	CcSEcCtD
Tolcapone—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0186	0.0186	CcSEcCtD
Tolcapone—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.0182	0.0182	CcSEcCtD
Tolcapone—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0171	0.0171	CcSEcCtD
Tolcapone—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0165	CcSEcCtD
Tolcapone—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0153	CcSEcCtD
Tolcapone—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0153	CcSEcCtD
Tolcapone—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0139	CcSEcCtD
Tolcapone—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0137	CcSEcCtD
Tolcapone—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Tolcapone—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0133	CcSEcCtD
Tolcapone—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0118	CcSEcCtD
Tolcapone—Hostility—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0118	CcSEcCtD
Tolcapone—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Tolcapone—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Tolcapone—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Tolcapone—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.01	0.01	CcSEcCtD
Tolcapone—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00993	0.00993	CcSEcCtD
Tolcapone—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00964	0.00964	CcSEcCtD
Tolcapone—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00954	0.00955	CcSEcCtD
Tolcapone—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00954	0.00955	CcSEcCtD
Tolcapone—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00945	0.00945	CcSEcCtD
Tolcapone—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00919	0.00919	CcSEcCtD
Tolcapone—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00919	0.00919	CcSEcCtD
Tolcapone—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00911	0.00911	CcSEcCtD
Tolcapone—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00902	0.00903	CcSEcCtD
Tolcapone—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00902	0.00903	CcSEcCtD
Tolcapone—Mania—Riluzole—amyotrophic lateral sclerosis	0.00894	0.00895	CcSEcCtD
Tolcapone—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00864	0.00864	CcSEcCtD
Tolcapone—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00864	0.00864	CcSEcCtD
Tolcapone—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00822	0.00822	CcSEcCtD
Tolcapone—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00809	0.00809	CcSEcCtD
Tolcapone—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00809	0.00809	CcSEcCtD
Tolcapone—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00773	0.00773	CcSEcCtD
Tolcapone—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00767	0.00768	CcSEcCtD
Tolcapone—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00756	0.00756	CcSEcCtD
Tolcapone—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00735	0.00735	CcSEcCtD
Tolcapone—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00725	0.00725	CcSEcCtD
Tolcapone—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00715	0.00716	CcSEcCtD
Tolcapone—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00715	0.00716	CcSEcCtD
Tolcapone—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0071	0.00711	CcSEcCtD
Tolcapone—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.0071	0.00711	CcSEcCtD
Tolcapone—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00701	CcSEcCtD
Tolcapone—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00688	0.00688	CcSEcCtD
Tolcapone—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00683	0.00684	CcSEcCtD
Tolcapone—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00667	CcSEcCtD
Tolcapone—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00658	0.00659	CcSEcCtD
Tolcapone—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.0065	0.00651	CcSEcCtD
Tolcapone—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0065	0.00651	CcSEcCtD
Tolcapone—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.0065	0.00651	CcSEcCtD
Tolcapone—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00643	0.00643	CcSEcCtD
Tolcapone—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00628	0.00628	CcSEcCtD
Tolcapone—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00588	CcSEcCtD
Tolcapone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00579	0.00579	CcSEcCtD
Tolcapone—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0057	0.0057	CcSEcCtD
Tolcapone—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00564	0.00565	CcSEcCtD
Tolcapone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00559	CcSEcCtD
Tolcapone—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00553	0.00554	CcSEcCtD
Tolcapone—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00543	0.00543	CcSEcCtD
Tolcapone—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00525	0.00526	CcSEcCtD
Tolcapone—Injury—Riluzole—amyotrophic lateral sclerosis	0.00514	0.00514	CcSEcCtD
Tolcapone—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00509	CcSEcCtD
Tolcapone—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00503	CcSEcCtD
Tolcapone—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00498	0.00498	CcSEcCtD
Tolcapone—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00496	0.00496	CcSEcCtD
Tolcapone—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00486	CcSEcCtD
Tolcapone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00484	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00472	CcSEcCtD
Tolcapone—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00472	CcSEcCtD
Tolcapone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00472	CcSEcCtD
Tolcapone—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00469	CcSEcCtD
Tolcapone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00465	CcSEcCtD
Tolcapone—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00465	CcSEcCtD
Tolcapone—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00461	CcSEcCtD
Tolcapone—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00456	CcSEcCtD
Tolcapone—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00449	CcSEcCtD
Tolcapone—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00449	CcSEcCtD
Tolcapone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00447	CcSEcCtD
Tolcapone—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00439	CcSEcCtD
Tolcapone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00417	CcSEcCtD
Tolcapone—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00408	CcSEcCtD
Tolcapone—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00408	CcSEcCtD
Tolcapone—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00408	CcSEcCtD
Tolcapone—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00398	CcSEcCtD
Tolcapone—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00393	CcSEcCtD
Tolcapone—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00382	CcSEcCtD
Tolcapone—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00377	CcSEcCtD
Tolcapone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00376	CcSEcCtD
Tolcapone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00369	CcSEcCtD
Tolcapone—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00366	CcSEcCtD
Tolcapone—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00364	CcSEcCtD
Tolcapone—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00364	CcSEcCtD
Tolcapone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00359	CcSEcCtD
Tolcapone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00357	CcSEcCtD
Tolcapone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00357	CcSEcCtD
Tolcapone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00355	CcSEcCtD
Tolcapone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00354	CcSEcCtD
Tolcapone—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00349	CcSEcCtD
Tolcapone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00347	CcSEcCtD
Tolcapone—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00343	CcSEcCtD
Tolcapone—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00341	CcSEcCtD
Tolcapone—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00333	CcSEcCtD
Tolcapone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00328	CcSEcCtD
Tolcapone—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00328	CcSEcCtD
Tolcapone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00327	CcSEcCtD
Tolcapone—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00325	CcSEcCtD
Tolcapone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00325	CcSEcCtD
Tolcapone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00324	CcSEcCtD
Tolcapone—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00323	CcSEcCtD
Tolcapone—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00322	CcSEcCtD
Tolcapone—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0032	CcSEcCtD
Tolcapone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00309	CcSEcCtD
Tolcapone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00296	CcSEcCtD
Tolcapone—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00294	CcSEcCtD
Tolcapone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00293	CcSEcCtD
Tolcapone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00292	CcSEcCtD
Tolcapone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00289	CcSEcCtD
Tolcapone—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00286	CcSEcCtD
Tolcapone—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0028	CcSEcCtD
Tolcapone—Tension—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00279	CcSEcCtD
Tolcapone—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00279	CcSEcCtD
Tolcapone—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00276	CcSEcCtD
Tolcapone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00273	CcSEcCtD
Tolcapone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00266	CcSEcCtD
Tolcapone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00264	CcSEcCtD
Tolcapone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00263	CcSEcCtD
Tolcapone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00261	CcSEcCtD
Tolcapone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00257	CcSEcCtD
Tolcapone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00256	CcSEcCtD
Tolcapone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00255	CcSEcCtD
Tolcapone—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00251	CcSEcCtD
Tolcapone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0025	CcSEcCtD
Tolcapone—Cough—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00248	CcSEcCtD
Tolcapone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00246	CcSEcCtD
Tolcapone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00242	CcSEcCtD
Tolcapone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00242	CcSEcCtD
Tolcapone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00242	CcSEcCtD
Tolcapone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00241	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0024	CcSEcCtD
Tolcapone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00239	CcSEcCtD
Tolcapone—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00237	CcSEcCtD
Tolcapone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00234	CcSEcCtD
Tolcapone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00232	CcSEcCtD
Tolcapone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00231	CcSEcCtD
Tolcapone—Shock—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00228	CcSEcCtD
Tolcapone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00228	CcSEcCtD
Tolcapone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00227	CcSEcCtD
Tolcapone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00227	CcSEcCtD
Tolcapone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00225	CcSEcCtD
Tolcapone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00224	CcSEcCtD
Tolcapone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00221	CcSEcCtD
Tolcapone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00217	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00212	CcSEcCtD
Tolcapone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00208	CcSEcCtD
Tolcapone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00207	CcSEcCtD
Tolcapone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00206	CcSEcCtD
Tolcapone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00204	CcSEcCtD
Tolcapone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00202	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.002	0.002	CcSEcCtD
Tolcapone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.002	0.002	CcSEcCtD
Tolcapone—Pain—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00199	CcSEcCtD
Tolcapone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00199	CcSEcCtD
Tolcapone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00191	CcSEcCtD
Tolcapone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0019	CcSEcCtD
Tolcapone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00184	CcSEcCtD
Tolcapone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00184	CcSEcCtD
Tolcapone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00184	CcSEcCtD
Tolcapone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00171	CcSEcCtD
Tolcapone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00167	CcSEcCtD
Tolcapone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00164	CcSEcCtD
Tolcapone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00159	CcSEcCtD
Tolcapone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00154	CcSEcCtD
Tolcapone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00148	CcSEcCtD
Tolcapone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00146	CcSEcCtD
Tolcapone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00146	CcSEcCtD
Tolcapone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00145	CcSEcCtD
Tolcapone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00138	CcSEcCtD
Tolcapone—Tolmetin—PTGS2—amyotrophic lateral sclerosis	0.000362	1	CrCbGaD
